Antigen targets of remission-inducing immune therapy are expressed on CML progenitor cells

Por Biernacki, Melinda A., Marina, Ovidiu, Zhang, Wandi, Liu, Fenglong, Bruns, Ingmar, Cai, Ann, Neuberg, Donna, Canning, Christine M., Alyea, Edwin P., Soiffer, Robert J., Brusic, Vladimir, Ritz, Jerome, Wu, Catherine J.
Publicado em 2010

Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid–immunoglobulin complexes in humans

Por Lin, Yun, Zhang, Li, Cai, Ann X., Lee, Mark, Zhang, Wandi, Neuberg, Donna, Canning, Christine M., Soiffer, Robert J., Alyea, Edwin P., Ritz, Jerome, Hacohen, Nir, Means, Terry K., Wu, Catherine J.
Publicado em 2011

Mutated BCR-ABL Generates Immunogenic T Cell Epitopes In CML Patients

Por Cai, Ann, Keskin, Derin B., DeLuca, David S., Alonso, Anselmo, Zhang, Wandi, Zhang, Guang Lan, Hammond, Naa Norkor, Nardi, Valentina, Stone, Richard M., Neuberg, Donna, Sidney, John, Brusic, Vladimir, Wu, Catherine J.
Publicado em 2012

Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include non-mutated B cell antigens

Por Marina, Ovidiu, Hainz, Ursula, Biernacki, Melinda A., Zhang, Wandi, Cai, Ann, Duke-Cohan, Jonathan S., Liu, Fenglong, Brusic, Vladimir, Neuberg, Donna, Kutok, Jeffery L., Alyea, Edwin P., Canning, Christine M., Soiffer, Robert J., Ritz, Jerome, Wu, Catherine J.
Publicado em 2010

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α

Por Shealy, David, Cai, Ann, Staquet, Kim, Baker, Audrey, Lacy, Eilyn R, Johns, Laura, Vafa, Omid, Gunn, George, Tam, Susan, Sague, Sarah, Wang, Dana, Brigham-Burke, Mike, Dalmonte, Paul, Emmell, Eva, Pikounis, Bill, Bugelski, Peter J, Zhou, Honghui, Scallon, Bernard, Giles-Komar, Jill
Publicado em 2010